Eclipsebio has acquired Terrain Bio, a techbio company specializing in AI/ML RNA design and manufacturing analytics.
Machine learning is a powerful tool in computational biology, enabling the analysis of a wide range of biomedical data such as genomic sequences and biological imaging. But when researchers use ...
Eclipsebio Acquires Terrain Bio to Expand Its End-to-End AI Platform for the Design, Manufacturing, and Validation of RNA Therapeutics ...
Researchers have developed a machine learning model capable of predicting whether a patient with depression will respond to ...
Tevogen Bio begins pre-clinical effort for TVGN 920, signaling the start of its oncology treatment pipeline. Tevogen Bio created a data set containing known proteins in the HPV genome to identify ...
Jeremy Goecks (left) is the Assistant Center Director for Research Informatics at the Moffitt Cancer Center (FL, USA), where he is also an Associate Faculty Member in the Department of Machine ...
For Lucas Farnung, there is no question more fascinating than how a single fertilized egg develops into a fully-functioning human. As a structural biologist, he is studying this process on the ...
Converge Bio, the AI platform for accelerated drug discovery and development, announced today $25 million in Series A funding, bringing its total raised to $30 million. The round was led by Bessemer ...
On Sunday, April 14, students participating in Cornell’s Microbiome Hackathon wrapped up 28 hours of work by showing off their creations which included an app to predict one’s risk of neurological ...
A machine learning model has been developed that makes optical spectroscopy data easier and quicker to interpret. Researchers from Rice University (TX, USA) have developed a new machine learning ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results